Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: Subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J. Whellan, Pierluigi Tricoci, Edmond Chen, Zhen Huang, David Leibowitz, Pascal Vranckx, Gregary D. Marhefka, Claes Held, Jose C. Nicolau, Robert F. Storey, Witold Ruzyllo, Kurt Huber, Peter Sinnaeve, A. Teddy Weiss, Jean Pierre Dery, David J. Moliterno, Frans Van De Werf, Philip E. Aylward, Harvey D. White, Paul W. ArmstrongLars Wallentin, John Strony, Robert A. Harrington, Kenneth W. Mahaffey
Research output: Contribution to journal › Article › peer-review
42Scopus
citations
Fingerprint
Dive into the research topics of 'Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: Subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)'. Together they form a unique fingerprint.